NW
REGN icon

NewEdge Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History

NewEdge Wealth’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$603K Buy
967
+382
+65% +$260K 0.01% 807
2026
Q1 		$452K Sell
585
-781
-57% -$598K 0.01% 844
2025
Q4 		$1.05M Buy
1,366
+845
+162% +$574K 0.01% 612
2025
Q3 		$336K Buy
+521
New +$295K ﹤0.01% 848
2025
Q2 		– Sell
-669
Closed -$425K – 1022
2025
Q1 		$425K Sell
669
-40,096
-98% -$27.6M 0.01% 693
2024
Q4 		$29M Buy
40,765
+3,636
+10% +$3.05M 0.5% 51
2024
Q3 		$39M Buy
37,129
+858
+2% +$955K 0.7% 34
2024
Q2 		$38.1M Buy
36,271
+11
+0% +$10.7K 0.83% 28
2024
Q1 		$34M Buy
36,260
+3,541
+11% +$3.37M 0.76% 29
2023
Q4 		$28.7M Buy
32,719
+4,287
+15% +$3.53M 0.73% 32
2023
Q3 		$23.4M Buy
28,432
+7,099
+33% +$5.58M 0.74% 33
2023
Q2 		$15.3M Buy
21,333
+737
+4% +$568K 0.51% 54
2023
Q1 		$16.9M Buy
20,596
+983
+5% +$741K 0.64% 43
2022
Q4 		$14.2M Buy
19,613
+875
+5% +$646K 0.61% 46
2022
Q3 		$12.9M Buy
18,738
+1,864
+11% +$1.17M 0.61% 48
2022
Q2 		$9.97M Buy
16,874
+571
+4% +$371K 0.45% 59
2022
Q1 		$11.4M Buy
16,303
+6,989
+75% +$4.42M 0.51% 48
2021
Q4 		$5.88M Buy
+9,314
New +$5.73M 0.25% 101
2021
Q2 		– Sell
-1,188
Closed -$562K – 306
2021
Q1 		$562K Buy
+1,188
New +$578K 0.06% 209

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

NewEdge Wealth's REGN Position: Q2 2026 in Review

NewEdge Wealth increased its Regeneron Pharmaceuticals (REGN) stake by 65% in Q2 2026, buying an estimated $260K and bringing the position to 967 shares worth $603K. The position accounts for 0.01% of the portfolio, ranked #807.

NewEdge Wealth first reported a position in REGN in Q1 2021 and has held it in 19 quarters since. The position peaked at $39M in Q3 2024. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • NewEdge Wealth held 967 shares of Regeneron Pharmaceuticals worth $603K as of Q2 2026.
  • NewEdge Wealth bought 382 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $260K.
  • Regeneron Pharmaceuticals made up 0.01% of NewEdge Wealth's portfolio in Q2 2026, its #807 holding.
  • NewEdge Wealth first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 19 quarters since.
  • NewEdge Wealth's Regeneron Pharmaceuticals position peaked at $39M in Q3 2024.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on NewEdge Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.